AstraZeneca Pharma India Limited (BOM:506820)
India flag India · Delayed Price · Currency is INR
8,826.70
-244.10 (-2.69%)
At close: Feb 12, 2026

AstraZeneca Pharma India Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
220,668215,159133,01081,18363,88675,255
Market Cap Growth
25.96%61.76%63.84%27.07%-15.11%25.87%
Enterprise Value
217,016210,362127,86176,55260,48472,857
Last Close Price
8826.708577.015284.393211.622520.502967.13
PE Ratio
109.82185.9082.3581.76103.7180.66
PS Ratio
10.1312.5410.278.097.939.25
PB Ratio
27.6227.9318.6813.7912.4916.50
P/TBV Ratio
27.6227.9518.7413.7912.4916.50
P/FCF Ratio
-338.25777.38163.1270.0777.53
P/OCF Ratio
-329.19477.25139.2763.3871.82
EV/Sales Ratio
9.9712.269.877.637.518.96
EV/EBITDA Ratio
71.7184.6769.8147.4573.1654.94
EV/EBIT Ratio
87.6397.9374.5851.4387.2062.67
EV/FCF Ratio
-330.71747.29153.8166.3375.06
Debt / Equity Ratio
0.040.050.010.010.020.03
Debt / EBITDA Ratio
0.110.140.020.040.100.09
Debt / FCF Ratio
-0.560.270.140.100.13
Net Debt / Equity Ratio
-0.46-0.65-0.70-0.84-0.86-0.75
Net Debt / EBITDA Ratio
-1.23-2.01-2.73-3.06-5.32-2.56
Net Debt / FCF Ratio
--7.87-29.28-9.91-4.82-3.50
Asset Turnover
-1.321.261.090.991.10
Inventory Turnover
-2.502.872.222.111.85
Quick Ratio
-1.051.891.611.641.46
Current Ratio
-1.912.612.182.122.04
Return on Equity (ROE)
-15.62%24.84%18.05%12.73%22.74%
Return on Assets (ROA)
-10.34%10.39%10.11%5.32%9.81%
Return on Invested Capital (ROIC)
42.08%66.13%82.29%131.87%54.86%71.20%
Return on Capital Employed (ROCE)
-26.40%23.80%24.80%13.20%24.70%
Earnings Yield
0.91%0.54%1.21%1.22%0.96%1.24%
FCF Yield
-0.30%0.13%0.61%1.43%1.29%
Dividend Yield
0.36%0.37%0.45%0.50%0.40%0.07%
Payout Ratio
-51.84%24.77%20.14%8.12%5.36%
Total Shareholder Return
0.39%0.37%0.45%0.50%0.40%0.07%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.